Data Scientist R&D Digital Innovation

Location: Biberach, Germany
Job Type: Full-Time
Employer: Boehringer Ingelheim
Building on emerging data-driven digital technologies we want to generate new insights in uncharted territory of disease biology and accelerate the discovery and development of high quality therapies. A new team has been formed to pave the way for our digital journey. If you are a game changer with a hands on mentality join the team and let the adventure begin.

Tasks & responsibilities

  • You design and build the next-generation of analytics engines and services based on your strong expertise in data mining, statistics and machine learning.
  • The interatctions with user / domain experts from all R&D functions helps you to understand problem statements and design data science use cases.
  • Furthermore, you collaborate with developers, data engineers, UI/UX designers and architects for the implementation of scalable solutions.
  • Through internal and external networking, collaboration and experimentation, you provide thought leadership to advance the discipline at BI.
  • You identify innovative and transformative use cases for advanced analytics / machine learning in all areas of R&D and across functions.
  • In addition, you lead the data science part of digital initiatives as a member of a use case team and in collaboration with R&D functions and partners (e.g. IT or external partners).
  • You are looking forward to internalize trends in data science, including input from other industries and explore opportunities for transformative use cases in pharma R&D.

Requirements

  • PhD in computer sciences, mathematics, physics, bioinformatics or a related life sciences field
  • Several years of relevant work experience in data science, machine learning and in working in multidisciplinary environments
  • Familiarity with life science data domains is a plus
  • Experience in professional handling of large data volumes from various sources
  • Excellent in scientific programming and profound knowledge in statistical analysis software and visualization tools (e.g. R, Python, Spotfire, Tableau, etc.)
  • Strong communicator, open for innovation and a passionate team player
  • Fluent English (written and spoken)

Apply for this job

About Boehringer Ingelheim
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry's top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.

Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects such as the "Making More Health" initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees' different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

Smartphone Photos can be Used to Detect …

A picture of a person's inner eyelid taken with a standard smartphone camera can be used to screen for anemia, according to a new study published this week in the...

Exscientia Accelerates COVID-19 Drug Dis…

Exscientia has received a grant from the Bill & Melinda Gates Foundation and Gates Philanthropy Partners, as part of the COVID-19 Therapeutics Accelerator. This is to expedite the optimisation of...

Collaboration Between AbbVie, Biogen an…

The access to the world's largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a genetic exome sequence analysis collaboration between AbbVie (NYSE:...

It's Going to be Quite a Handover…

Health and social care secretary Matt Hancock has been abruptly replaced by Sajid Javid. The Highland Marketing advisory board consider the huge agenda he is now facing, and what it...

Philips and Cognizant Collaborate to Int…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Cognizant (Nasdaq: CTSH), a world-leading professional services firm, announced a new collaboration to develop end-to-end digital health...

Philips Accelerates Stroke Diagnosis and…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced a strategic partnership agreement with NICO.LAB, a MedTech stroke care company. Together with the recently expanded stroke...

Fujitsu Announces Support of AWS for Hea…

Fujitsu in the UK has announced its support of the AWS for Health initiative from Amazon Web Services (AWS) by bringing Epic in the Cloud to NHS trusts and UK...

Ethics and Governance of Artificial Inte…

Artificial Intelligence (AI) refers to the ability of algorithms encoded in technology to learn from data so that they can perform automated tasks without every step in the process having...

Open Call HORIZON-HLTH-2021-TOOL-06-01: …

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 5 "Unlocking the full potential of new tools, technologies and digital...

New High-Tech Portal Launched to Speed H…

Researchers at the University of Maryland School of Medicine (UMSOM) launched a new online tool that could more quickly advance medical discoveries to reverse progressive hearing loss. The tool enables...

Artificial Intelligence Models to Analyz…

Artificial intelligence tools and deep learning models are a powerful tool in cancer treatment. They can be used to analyze digital images of tumor biopsy samples, helping physicians quickly classify...

Policy, Progress, Pace: Is the NHS Final…

Opinion Article by Lynette Ousby, UK Managing Director, Alcidion. There is a new energy emerging that might shake up the health tech market, and long-embedded challenges around siloed data and technologies. Political...